Experimental cutaneous Leishmaniasis: A powerful model to study in vivo the mechanisms underlying genetic differences in Th subset differentiation

European Journal of Dermatology

Volumn 12, Issue 4, 2002, Pages 316-318

  Louis, Jacques ^a   Gumy, Alain ^a   Voigt, Heike ^a   Röcken, Martin ^a   Launois, Pascal ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

CD4+ T cells; L. major

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENETIC DIFFERENCE; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; HELPER CELL; IN VIVO STUDY; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; SHORT SURVEY; SKIN INFECTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; DISEASE MODEL; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; REVIEW; SKIN LEISHMANIASIS;

ANIMAL; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; IMMUNITY, NATURAL; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; SUPPORT, NON-U.S. GOV'T; ANIMALS;

INTERLEUKIN 4;

EID: 0036018493     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (26)

1. The regulation of immunity to Leishmania major
2. + effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmanio major
3. + T cell response
4. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmonio major
5. + T cells producing IL-2 and IL-4
6. Functional diversity of helper T lymphocytes
7. Cytokines induce the development of functionally heterogenous T helper cell subsets
8. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating Leishmaniasis in normally resistant mice
9. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response
10. + T cell depletion and helper cells type 1 -selective cytokine therapy
11. Resolution of cutaneous leishmaniasis: Interleukin-12 iniates a protective T helper type 1 immune response
12. Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody. Evidence for a T cell-dependent, interferon-γ independent mechanism
13. -
14. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness
15. Expression cloning of a protective Leishmania antigen
16. + T cells in BALB/c mice infected with Leishmania major instructs Th2 cell development and susceptibility to infection
17. Resistance to Leishmania major induced by tolerance to a single antigen
18. Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope
19. + T cells to rapidly secrete IL-4 in BALB/c mice infected with Leishmania major
20. + T cells normally producing the early IL-4 instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice
21. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune type disorders in mice
22. + T helper type 1 cell responses to Candida albicans
23. T helper cell type 1-associated and cytotoxic T lymphocyte mediated tumor immunity is impaired in interleukin-4-deficient mice
24. A critical role for interleukin-4 un activating alloreactive CD4 T cells
25. Susceptibility to Leishmania major infection in IL-4 deficient mice
26. Interleukin-4 instructs Th1 responses and resistance to Leishmania major in susceptible BALB/c mice